Drug Cost Management Report

View more issues:

Articles in March, 2003 issue of Drug Cost Management Report

• How to select the right PBM
  by Chris Nee
• In South Dakota, a proposal by Gov. Mike Rounds ® to provide a discount plan for disabled and elderly people - State News in Brief - Brief Article
• The cost of prescription drug coverage will continue to increase at a rate of nearly 20% in 2003 - Drug Cost Studies in Brief - Brief Article
• Developing a reference-based pricing strategy for your formulary - excerpt from 'PBM Formulary Strategies' by Tim Watson - Excerpt
  by Tim Watson
• In Tennessee, the Medicaid program is considering a plan to use a single statewide formulary - State News in Brief - Brief Article
• A new study indicates that prescription drug copay incentives are effective in switching brands of proton pump inhibitors - PPIs - Drug Cost Studies in Brief
• Mail order delivers for PBMs and patients - data for pharmacy benefit management companies' usage of mail-order pharamcy services
  by Tim Watson
• Epilepsy drug Neurontin is the subject of a lawsuit against Pfizer and its subsidiary Parke-Davis - Legal News in Brief - Brief Article
• Health plan formularies contend with Claritin's OTC market debut - Illustration
• In South Carolina, Gov. Mark Sanford ® has approved a preferred drug list for Medicaid patients - State News in Brief - Brief Article
• Bipolar disorder may affect up to three times more Americans than previously believed - Drug Cost Studies in Brief - Brief Article
• Metadate CD extended release capsules was rated as better than previous ADHD treatments by 71% of patients - methylphenidate - Brief Article - Product/Service Evaluation
• Children in Louisiana are being prescribed stimulant medications for attention deficit hyperactivity disorder at four times the rate as children in the District of Columbia - ADHD - Drug Cost Studies in Brief
• Effexor XR has won FDA approval to treat social anxiety disorder - venlafaxine - Product News in Brief - Brief Article